Adenosine Receptors As Drug Targets for Treatment of Pulmonary Arterial Hypertension
Pulmonary arterial hypertension (PAH) is a clinical condition characterized by pulmonary arterial remodeling and vasoconstriction, which promote chronic vessel obstruction and elevation of pulmonary vascular resistance. Long-term right ventricular (RV) overload leads to RV dysfunction and failure, w...
Main Authors: | Allan K. N. Alencar, Guilherme C. Montes, Eliezer J. Barreiro, Roberto T. Sudo, Gisele Zapata-Sudo |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2017-12-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/article/10.3389/fphar.2017.00858/full |
Similar Items
-
ROCK Inhibition as Potential Target for Treatment of Pulmonary Hypertension
by: Tadeu L. Montagnoli, et al.
Published: (2021-06-01) -
Demographic and clinical characteristics of pulmonary arterial hypertension caused by schistosomiasis are indistinguishable from other etiologies
by: Adriano Assis Mendes, et al. -
Clinical Determinants and Prognostic Implications of Right Ventricular Dysfunction in Pulmonary Hypertension Caused by Chronic Lung Disease
by: Kurt W. Prins, et al.
Published: (2019-01-01) -
Cardiovascular magnetic resonance in pulmonary hypertension
by: Bradlow William M, et al.
Published: (2012-01-01) -
Novel p38 Mitogen-Activated Protein Kinase Inhibitor Reverses Hypoxia-Induced Pulmonary Arterial Hypertension in Rats
by: Grazielle Fernandes Silva, et al.
Published: (2022-07-01)